Abstract: According to an embodiment of the disclosure, a light emitting element may include a first semiconductor layer, an auxiliary layer on the first semiconductor layer, an active layer on the auxiliary layer, and a second semiconductor layer on the active layer. The auxiliary layer may include a first auxiliary layer surface adjacent to the first semiconductor layer and a second auxiliary layer surface which is a side surface adjacent to the first auxiliary layer surface, the active layer may include a well layer and a barrier layer, the auxiliary layer may have a superlattice structure, and the well layer may be on the first auxiliary layer surface without being on the second auxiliary layer surface of the auxiliary layer.

Abstract: Provided herein are compounds of formula (II): or a stereoisomer or tautomer thereof, or a pharmaceutically acceptable salt of any of the foregoing, wherein wherein m, n, p, R1, R2, R3, L1, L2, L3, R4, X1, X2, X3, and X4 are as defined herein. Also provided are methods of preparing compounds of formula (II), or a stereoisomer or tautomer thereof, or a pharmaceutically acceptable salt of any of the foregoing. Also provided are methods of inhibiting APOL1 and methods of treating an APOL1-mediated disease, disorder, or condition in an individual.

Abstract: A light-emitting element includes a first semiconductor layer doped to a first conductivity type, an active layer disposed on the first semiconductor layer, a second semiconductor layer disposed on the active layer, the second semiconductor layer doped to a second conductivity type, and a passivation layer surrounding surfaces of the active layer, the passivation layer including a side surface of the active layer, and the passivation layer includes a semiconductor material that matches a lattice of a semiconductor material contained in the active layer, the semiconductor material has a band gap energy higher than that of the semiconductor material contained in the active layer.

Abstract: A nanoscale thin film structure and implementing method thereof, and, more specifically, a nanoscale thin film structure of which target structure is designed with quantized thickness, and a method to implement the nanoscale thin film structure by which the performance of the manufactured nanodevice can be implemented the same as the designed performance, thereby applicable to high sensitivity high performance electronic/optical sensor devices.

Abstract: Provided herein are compounds of formula (II): or a stereoisomer or tautomer thereof, or a pharmaceutically acceptable salt of any of the foregoing, wherein wherein m, n, p, R1, R2, R3, L1, L2, L3, R4, X1, X2, X3, and X4 are as defined herein. Also provided are methods of preparing compounds of formula (II), or a stereoisomer or tautomer thereof, or a pharmaceutically acceptable salt of any of the foregoing. Also provided are methods of inhibiting APOL1 and methods of treating an APOL1-mediated disease, disorder, or condition in an individual.

Abstract: Provided herein are compounds of formula (A?): or a stereoisomer or tautomer thereof, or a pharmaceutically acceptable salt of any of the foregoing, wherein X1, X2, X3, X4, Ra, Rb, Rc, L, Q, and Y are as defined herein. Also provided are methods of N inhibiting APOL1 and methods of preparing compounds of formula (A?). Also provided are methods of inhibiting APOL1 and methods of treating an APOL1-mediated disease, disorder, or condition in an individual.

Abstract: Provided herein are compounds of formula (I?): or a stereoisomer or tautomer thereof, or a pharmaceutically acceptable salt of any of the foregoing, wherein Y2, Y3, L1, L2, X1, X2, X3, X4, X5, Q1, R1, R2, Rk, Rm, and Rn are as defined elsewhere herein. Also provided herein are methods of preparing compounds of formula (I?). Also provided herein are methods of inhibiting GYS1 and methods of treating a GYS1-mediated disease, disorder, or condition in an individual in need thereof.

Abstract: Provided herein are compounds of formula (II): or a stereoisomer or tautomer thereof, or a pharmaceutically acceptable salt of any of the foregoing, wherein m, n, R2, R3, R5, R6, R7, R8, R9, R10, R11a, R11b, and X are as defined elsewhere herein. Also provided herein are methods of preparing compounds of formula (II). Also provided herein are methods of inhibiting SLC6A19 and methods of treating a SLC6A19-mediated disease, disorder, or condition in an individual in need thereof.

Abstract: Provided herein are compounds of formula (II): or a stereoisomer or tautomer thereof, or a pharmaceutically acceptable salt of any of the foregoing, wherein m, n, p, R1, R2, R3, L1, L2, L3, R4, X1, X2, X3, and X4 are as defined herein. Also provided are methods of preparing compounds of formula (II), or a stereoisomer or tautomer thereof, or a pharmaceutically acceptable salt of any of the foregoing. Also provided are methods of inhibiting APOL1 and methods of treating an APOL1-mediated disease, disorder, or condition in an individual.

Abstract: Provided herein are compounds of formula (I?): or a stereoisomer or tautomer thereof, or a pharmaceutically acceptable salt of any of the foregoing, wherein Y2, Y3, L1, L2, X1, X2, X3, X4, X5, Q1, R1, R2, Rk, Rm, and Rn are as defined elsewhere herein. Also provided herein are methods of preparing compounds of formula (I?). Also provided herein are methods of inhibiting GYS1 and methods of treating a GYS1-mediated disease, disorder, or condition in an individual in need thereof.

Abstract: Provided herein are compounds of formula (II): or a stereoisomer or tautomer thereof, or a pharmaceutically acceptable salt of any of the foregoing, wherein m, n, p, R1, R2, R3, L1, L2, L3, R4, X1, X2, X3, and X4 are as defined herein. Also provided are methods of preparing compounds of formula (II), or a stereoisomer or tautomer thereof, or a pharmaceutically acceptable salt of any of the foregoing. Also provided are methods of inhibiting APOL1 and methods of treating an APOL1-mediated disease, disorder, or condition in an individual.

Abstract: Provided herein are compounds of formula (I?): or a stereoisomer or tautomer thereof, or a pharmaceutically acceptable salt of any of the foregoing, wherein Y2, Y3, L1, L2, X1, X2, X3, X4, X5, Q1, R1, R2, Rk, Rm, and Rn are as defined elsewhere herein. Also provided herein are methods of preparing compounds of formula (I?). Also provided herein are methods of inhibiting GYS1 and methods of treating a GYS1-mediated disease, disorder, or condition in an individual in need thereof.

Abstract: An air spring may include a first end member and a second end member spaced from each other; a flexible bellows having a first end portion airtightly coupled to the first end member, a second end portion airtightly coupled to the second end member, and a jacket mounted on the circumference of the flexible bellows and configured to support the flexible bellows.

Abstract: A nanoscale thin film structure and implementing method thereof, and, more specifically, a nanoscale thin film structure of which target structure is designed with quantized thickness, and a method to implement the nanoscale thin film structure by which the performance of the manufactured nanodevice can be implemented the same as the designed performance, thereby applicable to high sensitivity high performance electronic/optical sensor devices.

Abstract: An air spring may include a first end member and a second end member spaced from each other; a flexible bellows having a first end portion airtightly coupled to the first end member, a second end portion airtightly coupled to the second end member, and a jacket mounted on the circumference of the flexible bellows and configured to support the flexible bellows.

Abstract: An electronic device is provided. The electronic device includes a housing including a front plate, a back plate, and a side member surrounding a space between the front plate and the back plate. The side member includes a plurality of non-conductive portions and a conductive portion. The electronic device also includes a display module, and at least one wireless communication circuit. The electronic device also includes a printed circuit board (PCB). The camera assembly is exposed through a portion of the back plate. The camera assembly includes an image sensor mounted on the PCB, and a plurality of lenses. The camera assembly also includes a barrel that surrounds the plurality of lenses, and a camera bracket that surrounds at least part of the barrel. The camera assembly also includes a metal case that surrounds at least part of the camera assembly, and a shielding structure.

Abstract: A system for controlling a robot moving vertically and horizontally using a motor is provided. The system includes a detector suitable for generating a feedback signal by detecting physical status of the motor; and a controller suitable for detecting loading of a substrate on the robot based on the feedback signal during a vertical moving interval of the robot, and generating a control command in accordance with the detection of the loading of the substrate.

Abstract: An electronic device is provided. The electronic device includes a housing including a front plate, a back plate, and a side member surrounding a space between the front plate and the back plate. The side member includes a plurality of non-conductive portions and a conductive portion. The electronic device also includes a display module, and at least one wireless communication circuit. The electronic device also includes a printed circuit board (PCB). The camera assembly is exposed through a portion of the back plate. The camera assembly includes an image sensor mounted on the PCB, and a plurality of lenses. The camera assembly also includes a barrel that surrounds the plurality of lenses, and a camera bracket that surrounds at least part of the barrel. The camera assembly also includes a metal case that surrounds at least part of the camera assembly, and a shielding structure.

Abstract: A network-based motor control system-on-chip (SoC) and a motor control method. The network-based motor control system includes a network unit; a first processor for exchanging a first data with the network unit and processing a first task related to the first data; a motor; a motor control unit for controlling operation of the motor; a second processor for exchanging a second data related to the operation of the motor with the motor control unit and processing a second task related to the second data; and a data sharing unit for sharing processing results of the first task and the second task by the first processor and the second processor, in which the first task and the second task are concurrently processed.

Abstract: A portable terminal employing a near field communication antenna with a heat radiation function is provided. The portable terminal includes a cover provided for the portable terminal, and an antenna device mounted on an inner surface of the cover. The antenna device includes a near field communication antenna coupled to a location on the inner surface of the cover, a shield sheet coupled to an upper surface of the antenna, a heat radiation sheet coupled to an upper surface of the shield sheet so as to discharge heat transmitted from the portable terminal, and a protection cover coupled to an upper surface of the heat radiation sheet.